Annual Cash & Cash Equivalents
$3.17 B
-$697.76 M-18.03%
01 December 2023
Summary:
BeiGene annual cash & cash equivalents is currently $3.17 billion, with the most recent change of -$697.76 million (-18.03%) on 01 December 2023. During the last 3 years, it has fallen by -$1.20 billion (-27.51%).ONC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$2.70 B
+$109.28 M+4.21%
01 September 2024
Summary:
BeiGene quarterly cash and cash equivalents is currently $2.70 billion, with the most recent change of +$109.28 million (+4.21%) on 01 September 2024. Over the past year, it has dropped by -$469.87 million (-14.81%).ONC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ONC Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.8% |
| 3 y3 years | -27.5% | -38.3% |
| 5 y5 years | +413.2% | +337.2% |
ONC Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -27.5% | -40.4% |
BeiGene Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.70 B(+4.2%) |
| June 2024 | - | $2.59 B(-7.2%) |
| Mar 2024 | - | $2.79 B(-11.9%) |
| Dec 2023 | $3.17 B(-18.0%) | $3.17 B(+3.4%) |
| Sept 2023 | - | $3.07 B(-10.1%) |
| June 2023 | - | $3.41 B(-3.6%) |
| Mar 2023 | - | $3.54 B(-8.6%) |
| Dec 2022 | $3.87 B(-11.6%) | $3.87 B(-7.8%) |
| Sept 2022 | - | $4.20 B(-7.4%) |
| June 2022 | - | $4.53 B(+4.2%) |
| Mar 2022 | - | $4.35 B(-0.7%) |
| Dec 2021 | $4.38 B(+216.6%) | $4.38 B(+216.3%) |
| Sept 2021 | - | $1.38 B(-22.1%) |
| June 2021 | - | $1.78 B(-6.6%) |
| Mar 2021 | - | $1.90 B(+37.6%) |
| Dec 2020 | $1.38 B(+123.6%) | $1.38 B(-5.6%) |
| Sept 2020 | - | $1.46 B(+8.9%) |
| June 2020 | - | $1.35 B(-31.3%) |
| Mar 2020 | - | $1.96 B(+216.7%) |
| Dec 2019 | $618.01 M | $618.01 M(-27.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $856.15 M(-6.8%) |
| June 2019 | - | $918.95 M(+20.2%) |
| Mar 2019 | - | $764.49 M(+7.2%) |
| Dec 2018 | $712.94 M(+197.6%) | $712.94 M(+10.8%) |
| Sept 2018 | - | $643.49 M(+46.8%) |
| June 2018 | - | $438.42 M(-10.6%) |
| Mar 2018 | - | $490.63 M(+104.8%) |
| Dec 2017 | $239.60 M(+173.8%) | $239.60 M(+14.9%) |
| Sept 2017 | - | $208.51 M(-20.1%) |
| June 2017 | - | $261.01 M(+167.0%) |
| Mar 2017 | - | $97.75 M(+11.7%) |
| Dec 2016 | $87.51 M(+389.8%) | $87.51 M(+2.3%) |
| Sept 2016 | - | $85.53 M(+47.3%) |
| June 2016 | - | $58.08 M(-72.1%) |
| Mar 2016 | - | $208.51 M(+1066.9%) |
| Dec 2015 | $17.87 M(+28.6%) | $17.87 M(-34.9%) |
| Sept 2015 | - | $27.45 M(+9.1%) |
| June 2015 | - | $25.16 M(+81.0%) |
| Dec 2014 | $13.90 M(+254.0%) | $13.90 M |
| Dec 2013 | $3.93 M | - |
FAQ
- What is BeiGene annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BeiGene?
- What is BeiGene quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BeiGene?
- What is BeiGene quarterly cash and cash equivalents year-on-year change?
What is BeiGene annual cash & cash equivalents?
The current annual cash & cash equivalents of ONC is $3.17 B
What is the all time high annual cash & cash equivalents for BeiGene?
BeiGene all-time high annual cash & cash equivalents is $4.38 B
What is BeiGene quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ONC is $2.70 B
What is the all time high quarterly cash and cash equivalents for BeiGene?
BeiGene all-time high quarterly cash and cash equivalents is $4.53 B
What is BeiGene quarterly cash and cash equivalents year-on-year change?
Over the past year, ONC quarterly cash and cash equivalents has changed by -$469.87 M (-14.81%)